PAMU
Pictet Asset Management (UK)’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $420K | Sell |
4,400
-600
| -12% | -$57.3K | ﹤0.01% | 1278 |
|
|
2021
Q1 | $569K | Buy |
5,000
+300
| +6% | +$34.1K | ﹤0.01% | 1150 |
|
|
2020
Q4 | $651K | Hold |
4,700
| – | – | ﹤0.01% | 1084 |
|
|
2020
Q3 | $386K | Buy |
+4,700
| New | +$386K | ﹤0.01% | 1135 |
|
|
2019
Q3 | – | Sell |
-306,325
| Closed | -$19.5M | – | 1012 |
|
|
2019
Q2 | $19.5M | Sell |
306,325
-270,636
| -47% | -$17.2M | 0.04% | 387 |
|
|
2019
Q1 | $40M | Sell |
576,961
-325,142
| -36% | -$22.6M | 0.09% | 265 |
|
|
2018
Q4 | $39.2K | Buy |
902,103
+311,764
| +53% | +$13.6K | 0.1% | 257 |
|
|
2018
Q3 | $45.1M | Sell |
590,339
-50,634
| -8% | -$3.87M | 0.1% | 254 |
|
|
2018
Q2 | $49.3M | Sell |
640,973
-438,396
| -41% | -$33.7M | 0.12% | 231 |
|
|
2018
Q1 | $55M | Buy |
1,079,369
+64,900
| +6% | +$3.31M | 0.14% | 213 |
|
|
2017
Q4 | $47.1M | Buy |
1,014,469
+264,062
| +35% | +$12.2M | 0.12% | 228 |
|
|
2017
Q3 | $40M | Buy |
750,407
+161,196
| +27% | +$8.59M | 0.11% | 234 |
|
|
2017
Q2 | $31.7M | Buy |
589,211
+173,433
| +42% | +$9.34M | 0.1% | 265 |
|
|
2017
Q1 | $28.2M | Buy |
415,778
+28,228
| +7% | +$1.91M | 0.09% | 277 |
|
|
2016
Q4 | $27.2M | Buy |
387,550
+49,431
| +15% | +$3.48M | 0.1% | 257 |
|
|
2016
Q3 | $24M | Buy |
338,119
+143,592
| +74% | +$10.2M | 0.09% | 275 |
|
|
2016
Q2 | $14.2M | Buy |
194,527
+186,927
| +2,460% | +$13.7M | 0.06% | 357 |
|
|
2016
Q1 | $464K | Hold |
7,600
| – | – | ﹤0.01% | 794 |
|
|
2015
Q4 | $853K | Buy |
7,600
+4,700
| +162% | +$528K | ﹤0.01% | 791 |
|
|
2015
Q3 | $279K | Sell |
2,900
-28,700
| -91% | -$2.76M | ﹤0.01% | 843 |
|
|
2015
Q2 | $3.82M | Sell |
31,600
-10,700
| -25% | -$1.29M | 0.02% | 645 |
|
|
2015
Q1 | $2.39M | Buy |
+42,300
| New | +$2.39M | 0.01% | 719 |
|